Latest News of PRLD
We're Keeping An Eye On Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Rate
By Yahoo! Finance |
3 months ago
Investors are drawn to unprofitable companies due to potential growth, like Salesforce.com. However, Prelude Therapeutics shareholders may worry about its cash burn. Despite a solid cash runway, the t...